Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Molecular Therapy Oncolytics|January 19, 2023
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levelsJiang Lv, Le Qin, Ruocong Zhao, et al.Science Immunology|March 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activityYao Li, Jiongliang Wang, Linfu Zhou, et al.Oncoimmunology|December 15, 2018
DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cellsRuocong Zhao, Lin Cheng, Zhiwu Jiang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 8, 2025
RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and is a Potential Therapeutic TargetZhiping Wu, Zhe Wang, Diwei Zheng, et al.Journal of Hematology & Oncology|March 15, 2017
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cellsLe Qin, Yunxin Lai, Ruocong Zhao, et al.Biomarker Research|June 10, 2020
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growthLe Qin, Ruocong Zhao, Dongmei Chen, et al.Oncoimmunology|April 14, 2017
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cellsXinru Wei, Yunxin Lai, Jin Li, et al.Frontiers in Immunology|January 27, 2017
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular CarcinomaZhiwu Jiang, Xiaofeng Jiang, Suimin Chen, et al.Oncogene|January 16, 2021
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cellsShouheng Lin, Xuchao Zhang, Guohua Huang, et al.Frontiers in Immunology|June 13, 2022
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell MalignanciesDiwei Zheng, Xindong Wang, Lin Cheng, et al.Pageof 4